New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
CVRx, Inc.
CVRX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

231M

Medical - Devices

Next Earning date - 29 Oct 2024

231M

Medical - Devices

Next Earning date - 29 Oct 2024

10.63USD
Shape0.56 ( 5.51%)
Market Open
favorite-chart

Relative Strenght

8
favorite-chart

Volume Buzz

-69%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

68%

Quote Panel

Shape
Updated October 28, 2024
1W 4.73 % 1M 20.66 % 3M 14.67 % 1Y -17.66 %

Key Metrics

Shape
  • Market Cap

    231.47M


  • Shares Outstanding

    21.79M


  • Share in Float

    12.10M


  • Dividende

    0


  • Earning Date

    29 Oct 2024


  • Price Target

    10.625


  • Average Volume

    302698


  • Beta

    1.207


  • Range

    6.4-33.135


  • Industry

    Medical - Devices


  • Website

    https://www.cvrx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

4.94x

P/S Ratio

3.94x

P/B Ratio

0.5

Debt/Equity

-122.5%

Net Margin

$-2.6

EPS

How CVRX compares to sector?

P/E Ratio

Relative Strength

Shape

CVRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$66M

Shape458%

2025-Revenue

$2.07

Shape-219%

2025-EPS

$66M

Shape-377%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cantor Fitzgerald

initialise

Previous: Not converted

2024-09-10

Now: Overweight

William Blair

downgrade

Previous: Not converted

2024-05-01

Now: Market Perform

Zacks Investment Research

upgrade

Previous: Not converted

2022-04-26

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.48
vs -0.30

Q4.22

arrow
arrow

N/A

-0.51
vs -0.52

Q1.23

arrow
arrow

N/A

-0.55
vs -0.49

Q2.23

arrow
arrow

N/A

-0.56
vs -0.54

Q3.23

arrow
arrow

N/A

-0.43
vs -0.48

Q4.23

arrow
arrow

N/A

-0.44
vs -0.51

Q1.24

arrow
arrow

N/A

-1.04
vs -0.55

Q2.24

arrow
arrow

N/A

-0.65
vs -0.56

Q3.24

arrow
arrow

N/A

-0.47
vs -0.43

Q4.24

arrow
arrow

N/A

-0.45
vs -0.44

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+82%

6.2M  vs 3.4M

Q4.22

arrow
arrow

+96%

7.2M  vs 3.7M

Q1.23

arrow
arrow

+96%

8M  vs 4.1M

Q2.23

arrow
arrow

+89%

9.5M  vs 5M

Q3.23

arrow
arrow

+70%

10.5M  vs 6.2M

Q4.23

arrow
arrow

+58%

11.3M  vs 7.2M

Q1.24

arrow
arrow

+35%

10.8M  vs 8M

Q2.24

arrow
arrow

+24%

11.8M  vs 9.5M

Q3.24

arrow
arrow

+26%

13.2M  vs 10.5M

Q4.24

arrow
arrow

+31%

14.8M  vs 11.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.09

Q4.22

arrow
arrow

-10%

-0.10
vs -0.08

Q1.23

arrow
arrow

-11%

-0.11
vs -0.10

Q2.23

arrow
arrow

-13%

-0.13
vs -0.11

Q3.23

arrow
arrow

-11%

-0.11
vs -0.13

Q4.23

arrow
arrow

-12%

-0.12
vs -0.11

Q1.24

arrow
arrow

-33%

-0.33
vs -0.12

Q2.24

arrow
arrow

-25%

-0.25
vs -0.33

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

39

39
vs 37

5%

Q4.22

arrow
arrow

51

51
vs 39

31%

Q1.23

arrow
arrow

70

70
vs 51

37%

Q2.23

arrow
arrow

74

74
vs 70

6%

Q3.23

arrow
arrow

69

69
vs 74

-7%

Q4.23

arrow
arrow

90

90
vs 69

30%

Q1.24

arrow
arrow

92

92
vs 90

2%

Q2.24

arrow
arrow

76

76
vs 92

-17%

Earnings Growth

Latest News